

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transport (GO:0015893) | 8.67576531 |
| 2 | lysine catabolic process (GO:0006554) | 8.51046282 |
| 3 | lysine metabolic process (GO:0006553) | 8.51046282 |
| 4 | organic cation transport (GO:0015695) | 8.36896701 |
| 5 | phosphate ion transport (GO:0006817) | 8.34121167 |
| 6 | collecting duct development (GO:0072044) | 8.13390021 |
| 7 | quaternary ammonium group transport (GO:0015697) | 6.95831291 |
| 8 | response to mercury ion (GO:0046689) | 6.93532371 |
| 9 | phosphate ion transmembrane transport (GO:0035435) | 6.87081450 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.57052937 |
| 11 | actin filament depolymerization (GO:0030042) | 6.54083851 |
| 12 | drug catabolic process (GO:0042737) | 6.35037026 |
| 13 | cardiovascular system development (GO:0072358) | 6.33354301 |
| 14 | renal absorption (GO:0070293) | 6.31224552 |
| 15 | * excretion (GO:0007588) | 6.21906917 |
| 16 | positive regulation of catenin import into nucleus (GO:0035413) | 6.20469036 |
| 17 | cysteine metabolic process (GO:0006534) | 6.18194172 |
| 18 | tricarboxylic acid metabolic process (GO:0072350) | 6.14624588 |
| 19 | vitamin D metabolic process (GO:0042359) | 6.09630149 |
| 20 | exogenous drug catabolic process (GO:0042738) | 6.06350718 |
| 21 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 6.06262404 |
| 22 | metanephric nephron tubule development (GO:0072234) | 5.82844388 |
| 23 | metanephric tubule development (GO:0072170) | 5.82844388 |
| 24 | aspartate family amino acid catabolic process (GO:0009068) | 5.70556954 |
| 25 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.47375166 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 5.39983374 |
| 27 | metanephric nephron epithelium development (GO:0072243) | 5.39074714 |
| 28 | toxin transport (GO:1901998) | 5.27398799 |
| 29 | modified amino acid transport (GO:0072337) | 5.24475558 |
| 30 | homocysteine metabolic process (GO:0050667) | 5.21670633 |
| 31 | amino-acid betaine transport (GO:0015838) | 5.16656954 |
| 32 | carnitine transport (GO:0015879) | 5.16656954 |
| 33 | trivalent inorganic anion homeostasis (GO:0072506) | 5.16565961 |
| 34 | phosphate ion homeostasis (GO:0055062) | 5.16565961 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 5.15138965 |
| 36 | metanephric epithelium development (GO:0072207) | 5.03575068 |
| 37 | cell volume homeostasis (GO:0006884) | 4.96721125 |
| 38 | valine metabolic process (GO:0006573) | 4.90387387 |
| 39 | glutathione biosynthetic process (GO:0006750) | 4.87295097 |
| 40 | response to water (GO:0009415) | 4.77176925 |
| 41 | response to lead ion (GO:0010288) | 4.72377178 |
| 42 | proline metabolic process (GO:0006560) | 4.71601830 |
| 43 | negative regulation of metanephros development (GO:0072217) | 4.68963789 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.66211963 |
| 45 | L-phenylalanine metabolic process (GO:0006558) | 4.66211963 |
| 46 | glycoside metabolic process (GO:0016137) | 4.66119391 |
| 47 | 2-oxoglutarate metabolic process (GO:0006103) | 4.64266058 |
| 48 | nephron tubule formation (GO:0072079) | 4.62564605 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 4.56386544 |
| 50 | aromatic amino acid family catabolic process (GO:0009074) | 4.54073821 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.51230804 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 4.51230804 |
| 53 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.50259831 |
| 54 | fructose metabolic process (GO:0006000) | 4.48662582 |
| 55 | serine family amino acid metabolic process (GO:0009069) | 4.48495976 |
| 56 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.47090924 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46096370 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 4.46000051 |
| 59 | indole-containing compound catabolic process (GO:0042436) | 4.44173454 |
| 60 | indolalkylamine catabolic process (GO:0046218) | 4.44173454 |
| 61 | tryptophan catabolic process (GO:0006569) | 4.44173454 |
| 62 | nephron tubule development (GO:0072080) | 4.39855003 |
| 63 | pattern specification involved in kidney development (GO:0061004) | 4.39035327 |
| 64 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.38658223 |
| 65 | fatty acid beta-oxidation (GO:0006635) | 4.33160905 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 4.32108906 |
| 67 | branched-chain amino acid catabolic process (GO:0009083) | 4.31754081 |
| 68 | tryptophan metabolic process (GO:0006568) | 4.25836759 |
| 69 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.20717933 |
| 70 | acetyl-CoA metabolic process (GO:0006084) | 4.18041215 |
| 71 | polyol transport (GO:0015791) | 4.05684266 |
| 72 | NADH metabolic process (GO:0006734) | 4.03599950 |
| 73 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 4.01309679 |
| 74 | fatty acid oxidation (GO:0019395) | 3.97699557 |
| 75 | peptide biosynthetic process (GO:0043043) | 3.96642700 |
| 76 | carnitine metabolic process (GO:0009437) | 3.96614335 |
| 77 | response to parathyroid hormone (GO:0071107) | 3.92473641 |
| 78 | lipid oxidation (GO:0034440) | 3.89794019 |
| 79 | renal tubule development (GO:0061326) | 3.87894863 |
| 80 | vitamin transport (GO:0051180) | 3.84238044 |
| 81 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.83933956 |
| 82 | mesonephros development (GO:0001823) | 3.82761367 |
| 83 | urogenital system development (GO:0001655) | 3.82126374 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.81869002 |
| 85 | peptide catabolic process (GO:0043171) | 3.77586297 |
| 86 | glutamate metabolic process (GO:0006536) | 3.76953239 |
| 87 | response to copper ion (GO:0046688) | 3.76153576 |
| 88 | glomerular visceral epithelial cell development (GO:0072015) | 3.75496848 |
| 89 | inositol metabolic process (GO:0006020) | 3.70562110 |
| 90 | oligosaccharide catabolic process (GO:0009313) | 3.69447281 |
| 91 | response to growth hormone (GO:0060416) | 3.67088306 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.63920113 |
| 93 | sperm capacitation (GO:0048240) | 3.62986879 |
| 94 | nephron epithelium development (GO:0072009) | 3.62577970 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 3.61925676 |
| 96 | sulfur compound transport (GO:0072348) | 3.61710578 |
| 97 | response to vitamin A (GO:0033189) | 3.60601434 |
| 98 | nephron epithelium morphogenesis (GO:0072088) | 3.59066359 |
| 99 | nephron tubule morphogenesis (GO:0072078) | 3.59066359 |
| 100 | protein depolymerization (GO:0051261) | 3.57062292 |
| 101 | regulation of mitotic spindle organization (GO:0060236) | 3.55595093 |
| 102 | fatty acid catabolic process (GO:0009062) | 3.54442400 |
| 103 | tricarboxylic acid cycle (GO:0006099) | 3.53938702 |
| 104 | alpha-amino acid catabolic process (GO:1901606) | 3.52624177 |
| 105 | cellular response to vitamin D (GO:0071305) | 3.52526741 |
| 106 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.51953377 |
| 107 | negative regulation of sterol transport (GO:0032372) | 3.51742528 |
| 108 | negative regulation of cholesterol transport (GO:0032375) | 3.51742528 |
| 109 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.50903745 |
| 110 | kynurenine metabolic process (GO:0070189) | 3.50703272 |
| 111 | glutathione metabolic process (GO:0006749) | 3.50251848 |
| 112 | response to phenylpropanoid (GO:0080184) | 3.47689287 |
| 113 | sodium ion transport (GO:0006814) | 3.46645393 |
| 114 | glomerular epithelial cell development (GO:0072310) | 3.46466742 |
| 115 | indole-containing compound metabolic process (GO:0042430) | 3.45814718 |
| 116 | response to thyroid hormone (GO:0097066) | 3.44964289 |
| 117 | aromatic amino acid family metabolic process (GO:0009072) | 3.44835345 |
| 118 | sodium-independent organic anion transport (GO:0043252) | 3.44743380 |
| 119 | glutathione derivative biosynthetic process (GO:1901687) | 3.43967817 |
| 120 | glutathione derivative metabolic process (GO:1901685) | 3.43967817 |
| 121 | biotin metabolic process (GO:0006768) | 3.36419678 |
| 122 | hyperosmotic response (GO:0006972) | 3.34525778 |
| 123 | regulation of stem cell maintenance (GO:2000036) | 3.33849780 |
| 124 | organic acid catabolic process (GO:0016054) | 3.31667487 |
| 125 | carboxylic acid catabolic process (GO:0046395) | 3.31667487 |
| 126 | monocarboxylic acid catabolic process (GO:0072329) | 3.31052761 |
| 127 | ketone body metabolic process (GO:1902224) | 3.26894078 |
| 128 | dicarboxylic acid metabolic process (GO:0043648) | 3.26131900 |
| 129 | regulation of protein localization to cell surface (GO:2000008) | 3.25533487 |
| 130 | oxaloacetate metabolic process (GO:0006107) | 3.25349298 |
| 131 | regulation of catenin import into nucleus (GO:0035412) | 3.23341551 |
| 132 | bone remodeling (GO:0046849) | 3.21483481 |
| 133 | sulfur amino acid catabolic process (GO:0000098) | 3.20881021 |
| 134 | succinate metabolic process (GO:0006105) | 3.20766178 |
| 135 | regulation of spindle organization (GO:0090224) | 3.17600315 |
| 136 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.15699267 |
| 137 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.06608581 |
| 138 | cell differentiation involved in metanephros development (GO:0072202) | 3.04761927 |
| 139 | sister chromatid segregation (GO:0000819) | 3.04664934 |
| 140 | mitotic sister chromatid segregation (GO:0000070) | 2.95533048 |
| 141 | mesenchymal to epithelial transition (GO:0060231) | 2.92069084 |
| 142 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.89364998 |
| 143 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.89364998 |
| 144 | kidney epithelium development (GO:0072073) | 2.88333539 |
| 145 | microtubule depolymerization (GO:0007019) | 2.87753777 |
| 146 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.86155625 |
| 147 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.83308739 |
| 148 | negative regulation of kidney development (GO:0090185) | 2.81266365 |
| 149 | response to magnesium ion (GO:0032026) | 2.77962981 |
| 150 | glycine metabolic process (GO:0006544) | 2.73477053 |
| 151 | specification of organ identity (GO:0010092) | 2.72754711 |
| 152 | S-adenosylmethionine metabolic process (GO:0046500) | 2.71844701 |
| 153 | response to salt stress (GO:0009651) | 2.66890638 |
| 154 | cellular response to ammonium ion (GO:0071242) | 2.66114140 |
| 155 | DNA ligation (GO:0006266) | 2.64478018 |
| 156 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.64283878 |
| 157 | thyroid gland development (GO:0030878) | 2.60556027 |
| 158 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.60495155 |
| 159 | renal system process (GO:0003014) | 2.60462229 |
| 160 | mammary gland alveolus development (GO:0060749) | 2.56621513 |
| 161 | * inorganic anion transport (GO:0015698) | 2.55416947 |
| 162 | ERK1 and ERK2 cascade (GO:0070371) | 2.54196061 |
| 163 | chromosome condensation (GO:0030261) | 2.51792231 |
| 164 | positive regulation of digestive system process (GO:0060456) | 2.49866483 |
| 165 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.47625630 |
| 166 | kidney development (GO:0001822) | 2.44571465 |
| 167 | * chloride transmembrane transport (GO:1902476) | 2.42645326 |
| 168 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.40142488 |
| 169 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.7631201 |
| 170 | urate metabolic process (GO:0046415) | 10.4826503 |
| 171 | drug transmembrane transport (GO:0006855) | 10.1665693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 6.39740326 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.25290250 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.11908899 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.59174234 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.32376704 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.10495368 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.71242435 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.64228271 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.61087444 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.41866916 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.23266952 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.11578086 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.94389306 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.94017837 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.88466754 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.86277852 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.84574523 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.82608545 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.64047698 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54442352 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.52476074 |
| 22 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.46159114 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.45583309 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.30506864 |
| 25 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.29850384 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.24881755 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 2.19516656 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.18464224 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08442266 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.97084951 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.96974422 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96104917 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.90823335 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.84262036 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.78875206 |
| 36 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.74345666 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68857077 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.68185727 |
| 39 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.64765357 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63206467 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53761341 |
| 42 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53676524 |
| 43 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.53676524 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53264689 |
| 45 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.53204122 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53134453 |
| 47 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51699294 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49609606 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48360314 |
| 50 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.48139139 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.44116077 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43979404 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41104614 |
| 54 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38827051 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37414599 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37262860 |
| 57 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.36944912 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.36565361 |
| 59 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.36378160 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35640395 |
| 61 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.33196784 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.33134334 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32804470 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32367812 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28430554 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28141552 |
| 67 | * NFYB_21822215_ChIP-Seq_K562_Human | 1.27502774 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26610204 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25135089 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25135089 |
| 71 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.23206685 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23085342 |
| 73 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.22003333 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21365008 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20753951 |
| 76 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20644799 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20017292 |
| 78 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.18594306 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18222664 |
| 80 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.16291513 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15725948 |
| 82 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.15663575 |
| 83 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14356597 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14223927 |
| 85 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.14029448 |
| 86 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13576013 |
| 87 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.13104005 |
| 88 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 1.12234297 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12194360 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09746760 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09724945 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08955976 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08292617 |
| 94 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08024863 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07837058 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07436197 |
| 97 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.07386768 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 1.07281890 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06078733 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05367841 |
| 101 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05367841 |
| 102 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05006340 |
| 103 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.04842509 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04837875 |
| 105 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03333836 |
| 106 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03047107 |
| 107 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.01727536 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01674354 |
| 109 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01445852 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00470176 |
| 111 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99807282 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99545506 |
| 113 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98060473 |
| 114 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.96750424 |
| 115 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96320086 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96308822 |
| 117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95971756 |
| 118 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95822315 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95667042 |
| 120 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95343183 |
| 121 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95343183 |
| 122 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95343183 |
| 123 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95167062 |
| 124 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94214842 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94034165 |
| 126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93350988 |
| 127 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.92701613 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92121839 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92096880 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92003180 |
| 131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91902007 |
| 132 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91658166 |
| 133 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.91488315 |
| 134 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91232480 |
| 135 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90927662 |
| 136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89156211 |
| 137 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89156211 |
| 138 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88939144 |
| 139 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88258868 |
| 140 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87774120 |
| 141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87682138 |
| 142 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87518943 |
| 143 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.86972708 |
| 144 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86361166 |
| 145 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.85668436 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85369456 |
| 147 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84956216 |
| 148 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.84870940 |
| 149 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84503117 |
| 150 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.84041688 |
| 151 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83328299 |
| 152 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83293451 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82850199 |
| 154 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82360598 |
| 155 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.81947190 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81810756 |
| 157 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81716428 |
| 158 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80684177 |
| 159 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.80642796 |
| 160 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.79721656 |
| 161 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.79365888 |
| 162 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.79254228 |
| 163 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.79119851 |
| 164 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.78819344 |
| 165 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.78787529 |
| 166 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78182580 |
| 167 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77472510 |
| 168 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.77280820 |
| 169 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77173778 |
| 170 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77168045 |
| 171 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.77019506 |
| 172 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.76987835 |
| 173 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76848335 |
| 174 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.76714307 |
| 175 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.75954983 |
| 176 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.75723920 |
| 177 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75291968 |
| 178 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75289377 |
| 179 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.74923549 |
| 180 | * P68_20966046_ChIP-Seq_HELA_Human | 0.73133512 |
| 181 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72617743 |
| 182 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.72551081 |
| 183 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.72138554 |
| 184 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71755191 |
| 185 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71648362 |
| 186 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.71236292 |
| 187 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.70771175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.26580782 |
| 2 | MP0004043_abnormal_pH_regulation | 7.15702716 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.02605041 |
| 4 | MP0005332_abnormal_amino_acid | 4.88061369 |
| 5 | MP0003195_calcinosis | 4.72014198 |
| 6 | MP0009643_abnormal_urine_homeostasis | 4.14792046 |
| 7 | MP0001765_abnormal_ion_homeostasis | 4.13421942 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.90462124 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.63516249 |
| 10 | MP0001756_abnormal_urination | 3.52464827 |
| 11 | MP0005636_abnormal_mineral_homeostasis | 3.28926696 |
| 12 | MP0002136_abnormal_kidney_physiology | 3.19383307 |
| 13 | MP0003878_abnormal_ear_physiology | 3.12612747 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 3.12612747 |
| 15 | MP0001958_emphysema | 2.68711325 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.52398348 |
| 17 | MP0003252_abnormal_bile_duct | 2.29309848 |
| 18 | MP0005365_abnormal_bile_salt | 2.06455142 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.02721844 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.93282713 |
| 21 | MP0004885_abnormal_endolymph | 1.82033388 |
| 22 | MP0003186_abnormal_redox_activity | 1.76919538 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.73209970 |
| 24 | MP0001270_distended_abdomen | 1.70200050 |
| 25 | MP0000538_abnormal_urinary_bladder | 1.59512703 |
| 26 | MP0005451_abnormal_body_composition | 1.57226797 |
| 27 | MP0010030_abnormal_orbit_morphology | 1.53416581 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52927743 |
| 29 | MP0002168_other_aberrant_phenotype | 1.44516344 |
| 30 | MP0000230_abnormal_systemic_arterial | 1.40997231 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.36929758 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.30782589 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.29171330 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.26894320 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.26197317 |
| 36 | MP0002135_abnormal_kidney_morphology | 1.24740363 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.21873131 |
| 38 | MP0005670_abnormal_white_adipose | 1.21520520 |
| 39 | MP0002928_abnormal_bile_duct | 1.14561625 |
| 40 | MP0003938_abnormal_ear_development | 1.12620422 |
| 41 | MP0003137_abnormal_impulse_conducting | 1.10637258 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.09587751 |
| 43 | MP0003693_abnormal_embryo_hatching | 1.07282593 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.05329615 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.05066814 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.03286622 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.02389861 |
| 48 | MP0003283_abnormal_digestive_organ | 1.00360294 |
| 49 | MP0001293_anophthalmia | 0.98347696 |
| 50 | MP0000566_synostosis | 0.98089258 |
| 51 | MP0000049_abnormal_middle_ear | 0.94684597 |
| 52 | MP0005535_abnormal_body_temperature | 0.94099779 |
| 53 | MP0009672_abnormal_birth_weight | 0.93632685 |
| 54 | MP0001764_abnormal_homeostasis | 0.93420892 |
| 55 | MP0003646_muscle_fatigue | 0.89403393 |
| 56 | MP0002233_abnormal_nose_morphology | 0.87850235 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 0.85505047 |
| 58 | MP0004147_increased_porphyrin_level | 0.84163717 |
| 59 | MP0002234_abnormal_pharynx_morphology | 0.82130010 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 0.81318525 |
| 61 | MP0002132_abnormal_respiratory_system | 0.80420944 |
| 62 | MP0005395_other_phenotype | 0.80220039 |
| 63 | MP0002282_abnormal_trachea_morphology | 0.80173885 |
| 64 | MP0005367_renal/urinary_system_phenotyp | 0.79656636 |
| 65 | MP0000516_abnormal_urinary_system | 0.79656636 |
| 66 | MP0003638_abnormal_response/metabolism_ | 0.78552644 |
| 67 | MP0003942_abnormal_urinary_system | 0.77859540 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 0.77435733 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 0.77131208 |
| 70 | MP0006054_spinal_hemorrhage | 0.76820069 |
| 71 | MP0001661_extended_life_span | 0.76736761 |
| 72 | MP0000747_muscle_weakness | 0.75995480 |
| 73 | MP0002163_abnormal_gland_morphology | 0.75099609 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.72528059 |
| 75 | MP0005410_abnormal_fertilization | 0.72354263 |
| 76 | MP0001666_abnormal_nutrient_absorption | 0.72223758 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.72191487 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.71837238 |
| 79 | MP0000026_abnormal_inner_ear | 0.71002483 |
| 80 | MP0009703_decreased_birth_body | 0.68362929 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.68296740 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.66831412 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.66381940 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.65284831 |
| 85 | MP0002796_impaired_skin_barrier | 0.65033550 |
| 86 | MP0000681_abnormal_thyroid_gland | 0.62619572 |
| 87 | MP0002938_white_spotting | 0.61539280 |
| 88 | MP0003718_maternal_effect | 0.61530034 |
| 89 | MP0003698_abnormal_male_reproductive | 0.61486463 |
| 90 | MP0004272_abnormal_basement_membrane | 0.61050546 |
| 91 | MP0009764_decreased_sensitivity_to | 0.60807744 |
| 92 | MP0005165_increased_susceptibility_to | 0.60442642 |
| 93 | MP0002697_abnormal_eye_size | 0.59598838 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.57808881 |
| 95 | MP0004036_abnormal_muscle_relaxation | 0.57662561 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.57562764 |
| 97 | MP0001929_abnormal_gametogenesis | 0.57469460 |
| 98 | MP0004484_altered_response_of | 0.56368401 |
| 99 | MP0003959_abnormal_lean_body | 0.55277893 |
| 100 | MP0003937_abnormal_limbs/digits/tail_de | 0.54823622 |
| 101 | MP0000678_abnormal_parathyroid_gland | 0.54689179 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54673115 |
| 103 | MP0003077_abnormal_cell_cycle | 0.53332195 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.53214862 |
| 105 | MP0000371_diluted_coat_color | 0.52960867 |
| 106 | MP0000534_abnormal_ureter_morphology | 0.52803655 |
| 107 | MP0000609_abnormal_liver_physiology | 0.51240345 |
| 108 | MP0005501_abnormal_skin_physiology | 0.51103616 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.50950813 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48465280 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.47620999 |
| 112 | MP0003119_abnormal_digestive_system | 0.47243991 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.47218135 |
| 114 | MP0002115_abnormal_skeleton_extremities | 0.47055026 |
| 115 | MP0000598_abnormal_liver_morphology | 0.46846832 |
| 116 | MP0010329_abnormal_lipoprotein_level | 0.46816196 |
| 117 | MP0004858_abnormal_nervous_system | 0.46583254 |
| 118 | MP0006292_abnormal_olfactory_placode | 0.46575759 |
| 119 | MP0005248_abnormal_Harderian_gland | 0.46053351 |
| 120 | MP0004085_abnormal_heartbeat | 0.45632023 |
| 121 | MP0001145_abnormal_male_reproductive | 0.45176094 |
| 122 | MP0008469_abnormal_protein_level | 0.45042521 |
| 123 | MP0003795_abnormal_bone_structure | 0.44429434 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.44235194 |
| 125 | MP0001286_abnormal_eye_development | 0.44087629 |
| 126 | MP0005391_vision/eye_phenotype | 0.43782622 |
| 127 | MP0003315_abnormal_perineum_morphology | 0.43653002 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.42542990 |
| 129 | MP0002092_abnormal_eye_morphology | 0.42514606 |
| 130 | MP0005408_hypopigmentation | 0.42287354 |
| 131 | MP0002210_abnormal_sex_determination | 0.41966124 |
| 132 | MP0004742_abnormal_vestibular_system | 0.41961057 |
| 133 | MP0003329_amyloid_beta_deposits | 0.41574724 |
| 134 | MP0003011_delayed_dark_adaptation | 0.40565800 |
| 135 | MP0003953_abnormal_hormone_level | 0.40388797 |
| 136 | MP0003879_abnormal_hair_cell | 0.40382584 |
| 137 | MP0002161_abnormal_fertility/fecundity | 0.40374553 |
| 138 | MP0002127_abnormal_cardiovascular_syste | 0.39769272 |
| 139 | MP0008932_abnormal_embryonic_tissue | 0.38481057 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.37693247 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.37135916 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.36883587 |
| 143 | MP0004233_abnormal_muscle_weight | 0.35800952 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.35487447 |
| 145 | MP0004084_abnormal_cardiac_muscle | 0.35213420 |
| 146 | MP0008775_abnormal_heart_ventricle | 0.34930468 |
| 147 | MP0001663_abnormal_digestive_system | 0.34443203 |
| 148 | MP0000163_abnormal_cartilage_morphology | 0.33875246 |
| 149 | MP0008872_abnormal_physiological_respon | 0.33227027 |
| 150 | MP0005330_cardiomyopathy | 0.32021007 |
| 151 | MP0002972_abnormal_cardiac_muscle | 0.31751243 |
| 152 | MP0005620_abnormal_muscle_contractility | 0.31678349 |
| 153 | MP0001727_abnormal_embryo_implantation | 0.30853372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypomagnesemia (HP:0002917) | 8.25608425 |
| 2 | * Increased circulating renin level (HP:0000848) | 7.59703782 |
| 3 | * Hypokalemic alkalosis (HP:0001949) | 7.45862458 |
| 4 | Abnormality of magnesium homeostasis (HP:0004921) | 7.02392200 |
| 5 | Gout (HP:0001997) | 7.01175176 |
| 6 | * Polyuria (HP:0000103) | 6.83833923 |
| 7 | * Metabolic alkalosis (HP:0200114) | 6.57864117 |
| 8 | * Abnormal urine output (HP:0012590) | 6.36611927 |
| 9 | Abnormal drinking behavior (HP:0030082) | 6.32079105 |
| 10 | Polydipsia (HP:0001959) | 6.32079105 |
| 11 | Tetany (HP:0001281) | 6.06067265 |
| 12 | * Abnormality of renal excretion (HP:0011036) | 6.01911347 |
| 13 | * Abnormality of chloride homeostasis (HP:0011422) | 5.90561895 |
| 14 | * Hyperactive renin-angiotensin system (HP:0000841) | 5.60788039 |
| 15 | Proximal tubulopathy (HP:0000114) | 5.50318911 |
| 16 | Hyperuricemia (HP:0002149) | 5.06289732 |
| 17 | Increased purine levels (HP:0004368) | 5.06289732 |
| 18 | Hyperglycinuria (HP:0003108) | 4.72190697 |
| 19 | * Abnormality of renin-angiotensin system (HP:0000847) | 4.69660562 |
| 20 | * Alkalosis (HP:0001948) | 4.67993367 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.59310294 |
| 22 | Abnormality of purine metabolism (HP:0004352) | 4.33072914 |
| 23 | Hypercalciuria (HP:0002150) | 4.31669287 |
| 24 | * Renal salt wasting (HP:0000127) | 4.30710152 |
| 25 | * Hyperaldosteronism (HP:0000859) | 4.17154432 |
| 26 | Generalized aminoaciduria (HP:0002909) | 4.05621808 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83532450 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.83532450 |
| 29 | Renal tubular acidosis (HP:0001947) | 3.68532594 |
| 30 | * Hypokalemia (HP:0002900) | 3.65310860 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.56001513 |
| 32 | Glycosuria (HP:0003076) | 3.56001513 |
| 33 | Ketoacidosis (HP:0001993) | 3.50002706 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18969069 |
| 35 | Hyperphosphaturia (HP:0003109) | 3.16547052 |
| 36 | Delayed epiphyseal ossification (HP:0002663) | 3.16352832 |
| 37 | Nephrocalcinosis (HP:0000121) | 3.15006978 |
| 38 | * Abnormality of potassium homeostasis (HP:0011042) | 3.13342498 |
| 39 | Hydroxyprolinuria (HP:0003080) | 3.07465357 |
| 40 | Abnormality of proline metabolism (HP:0010907) | 3.07465357 |
| 41 | Ketosis (HP:0001946) | 3.02028100 |
| 42 | Abnormal urine phosphate concentration (HP:0012599) | 3.00943605 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93352553 |
| 44 | Large eyes (HP:0001090) | 2.80141039 |
| 45 | Nephrolithiasis (HP:0000787) | 2.76264423 |
| 46 | Metaphyseal cupping (HP:0003021) | 2.68948575 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64642662 |
| 48 | Hyperglycinemia (HP:0002154) | 2.63228729 |
| 49 | Hypophosphatemia (HP:0002148) | 2.62788976 |
| 50 | Vascular calcification (HP:0004934) | 2.59580952 |
| 51 | Chondrocalcinosis (HP:0000934) | 2.58192470 |
| 52 | Rickets (HP:0002748) | 2.55392336 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.53302515 |
| 54 | Abnormality of Sharpey fibers (HP:0100685) | 2.42381924 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.39580679 |
| 56 | Hyperammonemia (HP:0001987) | 2.35690838 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.34600508 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.31140135 |
| 59 | Tubular atrophy (HP:0000092) | 2.30865010 |
| 60 | Vomiting (HP:0002013) | 2.30548823 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.27258796 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27258796 |
| 63 | Enlarged kidneys (HP:0000105) | 2.26660329 |
| 64 | * Dehydration (HP:0001944) | 2.25382725 |
| 65 | Renal tubular dysfunction (HP:0000124) | 2.25136322 |
| 66 | Metabolic acidosis (HP:0001942) | 2.16914915 |
| 67 | Tubulointerstitial fibrosis (HP:0005576) | 2.15528120 |
| 68 | * Generalized muscle weakness (HP:0003324) | 2.15359219 |
| 69 | Thin bony cortex (HP:0002753) | 2.15230435 |
| 70 | Confusion (HP:0001289) | 2.12556459 |
| 71 | Potter facies (HP:0002009) | 2.11036747 |
| 72 | Facial shape deformation (HP:0011334) | 2.11036747 |
| 73 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.10739540 |
| 74 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09831671 |
| 75 | Malnutrition (HP:0004395) | 2.06403421 |
| 76 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04685489 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.04575384 |
| 78 | Glomerulosclerosis (HP:0000096) | 2.03429116 |
| 79 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.99041086 |
| 80 | Lethargy (HP:0001254) | 1.98387040 |
| 81 | Abnormality of the costochondral junction (HP:0000919) | 1.95916582 |
| 82 | Lymphangioma (HP:0100764) | 1.92605796 |
| 83 | Abnormal tarsal ossification (HP:0008369) | 1.91923367 |
| 84 | * Abnormality of sodium homeostasis (HP:0010931) | 1.91544672 |
| 85 | Bicornuate uterus (HP:0000813) | 1.90642083 |
| 86 | Methylmalonic aciduria (HP:0012120) | 1.90228171 |
| 87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87118072 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84315248 |
| 89 | Nausea (HP:0002018) | 1.84162869 |
| 90 | * Hypotension (HP:0002615) | 1.82651020 |
| 91 | Abnormality of the renal medulla (HP:0100957) | 1.80144597 |
| 92 | * Adrenal overactivity (HP:0002717) | 1.78469357 |
| 93 | Hyperkalemia (HP:0002153) | 1.78402762 |
| 94 | Irritability (HP:0000737) | 1.72454076 |
| 95 | Metaphyseal irregularity (HP:0003025) | 1.69837505 |
| 96 | Metaphyseal dysplasia (HP:0100255) | 1.65558334 |
| 97 | Axonal loss (HP:0003447) | 1.65547955 |
| 98 | * Hyponatremia (HP:0002902) | 1.64017336 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 1.63025423 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 1.62310834 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 1.60982766 |
| 102 | Tachypnea (HP:0002789) | 1.59024696 |
| 103 | Neonatal onset (HP:0003623) | 1.56801941 |
| 104 | Focal segmental glomerulosclerosis (HP:0000097) | 1.52767314 |
| 105 | Paralysis (HP:0003470) | 1.52038499 |
| 106 | Intellectual disability, moderate (HP:0002342) | 1.43822930 |
| 107 | Pancreatic cysts (HP:0001737) | 1.37131892 |
| 108 | Abnormality of cochlea (HP:0000375) | 1.32882428 |
| 109 | High anterior hairline (HP:0009890) | 1.28971705 |
| 110 | Thyroid-stimulating hormone excess (HP:0002925) | 1.26616243 |
| 111 | Cystic liver disease (HP:0006706) | 1.24552170 |
| 112 | * Premature birth (HP:0001622) | 1.23279325 |
| 113 | Abnormal platelet function (HP:0011869) | 1.15950103 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.15950103 |
| 115 | Osteopenia (HP:0000938) | 1.15513973 |
| 116 | Small for gestational age (HP:0001518) | 1.14727097 |
| 117 | Hypothermia (HP:0002045) | 1.13027628 |
| 118 | Tubulointerstitial abnormality (HP:0001969) | 1.08664075 |
| 119 | Neonatal death (HP:0003811) | 1.06230193 |
| 120 | * Polyhydramnios (HP:0001561) | 1.01126169 |
| 121 | Occipital encephalocele (HP:0002085) | 1.01073147 |
| 122 | Abnormality of the renal cortex (HP:0011035) | 1.00356273 |
| 123 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 0.97403331 |
| 124 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 0.97251745 |
| 125 | Morphological abnormality of the inner ear (HP:0011390) | 0.94860682 |
| 126 | Abnormality of macular pigmentation (HP:0008002) | 0.91474306 |
| 127 | Renal dysplasia (HP:0000110) | 0.90508051 |
| 128 | Flared metaphyses (HP:0003015) | 0.89029653 |
| 129 | Abnormal ciliary motility (HP:0012262) | 0.86474875 |
| 130 | Broad distal phalanx of finger (HP:0009836) | 0.85920845 |
| 131 | Paresthesia (HP:0003401) | 0.85512545 |
| 132 | Abnormal foot bone ossification (HP:0010675) | 0.84908856 |
| 133 | Osteomalacia (HP:0002749) | 0.82651741 |
| 134 | Abnormal respiratory motile cilium physiology (HP:0012261) | 0.82023705 |
| 135 | 11 pairs of ribs (HP:0000878) | 0.81421434 |
| 136 | Goiter (HP:0000853) | 0.80404501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.93624811 |
| 2 | OXSR1 | 8.05530119 |
| 3 | WNK3 | 7.44718748 |
| 4 | STK39 | 5.67196919 |
| 5 | BCKDK | 2.31221959 |
| 6 | BUB1 | 2.14501990 |
| 7 | STK38L | 2.07420575 |
| 8 | NEK1 | 1.77403775 |
| 9 | WNK1 | 1.76571775 |
| 10 | PDK3 | 1.66524117 |
| 11 | PDK4 | 1.66524117 |
| 12 | SGK223 | 1.59365636 |
| 13 | SGK494 | 1.59365636 |
| 14 | PDK2 | 1.36628275 |
| 15 | STK38 | 1.01866446 |
| 16 | TNIK | 0.99768302 |
| 17 | MST4 | 0.97433786 |
| 18 | TAF1 | 0.94630335 |
| 19 | TIE1 | 0.92232425 |
| 20 | LMTK2 | 0.90870636 |
| 21 | SGK2 | 0.89427799 |
| 22 | NEK2 | 0.88224962 |
| 23 | BRSK2 | 0.87554012 |
| 24 | SGK3 | 0.84388693 |
| 25 | PLK4 | 0.81401419 |
| 26 | MST1R | 0.78622346 |
| 27 | LRRK2 | 0.76214831 |
| 28 | BRD4 | 0.73305566 |
| 29 | TGFBR2 | 0.70245179 |
| 30 | FGFR4 | 0.64925550 |
| 31 | PINK1 | 0.63235478 |
| 32 | GSK3A | 0.61959256 |
| 33 | EPHB1 | 0.57938781 |
| 34 | MAP3K3 | 0.57670463 |
| 35 | PAK4 | 0.57093972 |
| 36 | NLK | 0.56628635 |
| 37 | BRSK1 | 0.55512037 |
| 38 | DMPK | 0.53550330 |
| 39 | FGFR2 | 0.53148142 |
| 40 | PLK3 | 0.53083151 |
| 41 | PBK | 0.52879327 |
| 42 | GRK6 | 0.50535323 |
| 43 | CDK19 | 0.47731522 |
| 44 | PLK1 | 0.47333893 |
| 45 | WEE1 | 0.47329643 |
| 46 | SGK1 | 0.46706175 |
| 47 | PTK2 | 0.41795715 |
| 48 | MAP3K7 | 0.40985811 |
| 49 | ABL2 | 0.40470344 |
| 50 | MELK | 0.39729722 |
| 51 | EPHA2 | 0.39701899 |
| 52 | MYLK | 0.39550225 |
| 53 | UHMK1 | 0.39471992 |
| 54 | CASK | 0.39255468 |
| 55 | PASK | 0.39218225 |
| 56 | CDK8 | 0.39049947 |
| 57 | PRKAA1 | 0.38489059 |
| 58 | MAP3K10 | 0.37794748 |
| 59 | NUAK1 | 0.37416621 |
| 60 | AURKB | 0.36733555 |
| 61 | DYRK1B | 0.35325037 |
| 62 | KDR | 0.33643873 |
| 63 | PRKCI | 0.33406656 |
| 64 | ERN1 | 0.32700131 |
| 65 | ADRBK2 | 0.31788661 |
| 66 | PDPK1 | 0.31071359 |
| 67 | STK3 | 0.30464507 |
| 68 | TRIB3 | 0.29905496 |
| 69 | STK10 | 0.29607046 |
| 70 | FER | 0.29270097 |
| 71 | PTK6 | 0.27706689 |
| 72 | TESK1 | 0.27686091 |
| 73 | ZAK | 0.27581115 |
| 74 | MET | 0.27522411 |
| 75 | MAPK11 | 0.26943811 |
| 76 | NME2 | 0.25900749 |
| 77 | INSRR | 0.24657835 |
| 78 | PAK3 | 0.24317427 |
| 79 | DDR2 | 0.23476299 |
| 80 | PRKAA2 | 0.21778136 |
| 81 | TSSK6 | 0.21348269 |
| 82 | PRKD2 | 0.20595045 |
| 83 | BRAF | 0.20349246 |
| 84 | CCNB1 | 0.19131173 |
| 85 | EPHA4 | 0.18443248 |
| 86 | LATS1 | 0.18343565 |
| 87 | PTK2B | 0.17980872 |
| 88 | LATS2 | 0.17921604 |
| 89 | FGFR1 | 0.17809244 |
| 90 | PRKCZ | 0.17778709 |
| 91 | NTRK1 | 0.17250148 |
| 92 | MAPK10 | 0.17233656 |
| 93 | MAP2K3 | 0.16914497 |
| 94 | FLT3 | 0.16750892 |
| 95 | STK4 | 0.16618683 |
| 96 | PDK1 | 0.16306255 |
| 97 | SCYL2 | 0.16137746 |
| 98 | CLK1 | 0.15560387 |
| 99 | RIPK1 | 0.15178809 |
| 100 | TGFBR1 | 0.14803216 |
| 101 | BMPR1B | 0.14328045 |
| 102 | PRKCD | 0.13827738 |
| 103 | AKT2 | 0.13627042 |
| 104 | STK16 | 0.13408783 |
| 105 | MAP3K11 | 0.13323828 |
| 106 | STK11 | 0.12991165 |
| 107 | PLK2 | 0.12907880 |
| 108 | CDK1 | 0.12483673 |
| 109 | AURKA | 0.11977351 |
| 110 | ERBB2 | 0.11811122 |
| 111 | MAPK15 | 0.11511001 |
| 112 | FRK | 0.11296340 |
| 113 | PRKACG | 0.11203169 |
| 114 | PIM1 | 0.11074002 |
| 115 | EPHB2 | 0.10537049 |
| 116 | AKT3 | 0.10508569 |
| 117 | PNCK | 0.09041845 |
| 118 | PAK1 | 0.07478278 |
| 119 | PRKCA | 0.06587942 |
| 120 | PRKACA | 0.06478458 |
| 121 | ROCK1 | 0.06201887 |
| 122 | MAP3K2 | 0.06123139 |
| 123 | PRKG1 | 0.05976322 |
| 124 | CDK2 | 0.05341249 |
| 125 | SRPK1 | 0.05193404 |
| 126 | TTK | 0.05148147 |
| 127 | BMX | 0.04928324 |
| 128 | MAPK12 | 0.04806559 |
| 129 | CHEK2 | 0.04750284 |
| 130 | MTOR | 0.04212425 |
| 131 | ATM | 0.04093094 |
| 132 | PRKCH | 0.03803003 |
| 133 | PRKCB | 0.02904092 |
| 134 | ERBB4 | 0.02841670 |
| 135 | GSK3B | 0.02697378 |
| 136 | CHEK1 | 0.02576824 |
| 137 | NME1 | 0.01873672 |
| 138 | IRAK2 | 0.00855140 |
| 139 | CSNK1A1 | 0.00305247 |
| 140 | INSR | 0.00056750 |
| 141 | JAK2 | -3.0382571 |
| 142 | PRKCG | -0.0525328 |
| 143 | CSK | -0.0511919 |
| 144 | IGF1R | -0.0505569 |
| 145 | PRKACB | -0.0453701 |
| 146 | MINK1 | -0.0414373 |
| 147 | CSNK1E | -0.0412406 |
| 148 | ROCK2 | -0.0377212 |
| 149 | IRAK3 | -0.0294364 |
| 150 | PDGFRA | -0.0191044 |
| 151 | MARK3 | -0.0188432 |
| 152 | MAP3K14 | -0.0185770 |
| 153 | SRC | -0.0185293 |
| 154 | MAP2K2 | -0.0184668 |
| 155 | MAP3K8 | -0.0153968 |
| 156 | TAOK1 | -0.0014656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.69536148 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.64553959 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.50681517 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.39766805 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.29140878 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.24917099 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.22859534 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09584591 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.02563125 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.81750673 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.79405361 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39989396 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.36982309 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.35420079 |
| 15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.22784034 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12326238 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.10709825 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98169525 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87801058 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84444800 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84095224 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74223626 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72623274 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.71467565 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.68784246 |
| 26 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53551482 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53449092 |
| 28 | Mineral absorption_Homo sapiens_hsa04978 | 1.47077825 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44918856 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.40297522 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40223773 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37867651 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33764210 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.30588411 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25003125 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20064865 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14295926 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12512713 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11474539 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10961428 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05319093 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04414919 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.01404705 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99846408 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99748789 |
| 46 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.98251191 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97160925 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95654891 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94902781 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90305245 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86768039 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86052214 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84616060 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83872286 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83499074 |
| 56 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83211523 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 0.78878827 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74998733 |
| 59 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.74018951 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71207250 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70901463 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68706208 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68261941 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67834478 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.67294143 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66915478 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66451151 |
| 68 | Melanoma_Homo sapiens_hsa05218 | 0.65293176 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64624832 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64053593 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.63051133 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54611093 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54221467 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53268819 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52493387 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.51702284 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51329615 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49496846 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.49335604 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47796420 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47649775 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46591921 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46448049 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45755843 |
| 85 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44593322 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42971182 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42901711 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41172993 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39768350 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.39454635 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39165663 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.37916604 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35471802 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35206743 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.33503275 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32806748 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31076523 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30833942 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.30482485 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27979856 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.27351129 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27189505 |
| 103 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.25337682 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24058129 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23596661 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23579385 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23000794 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21006400 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19661107 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18477584 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.16889995 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.16442822 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15705680 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13159545 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11202443 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.10624979 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.10117152 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.08991175 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08608614 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05677488 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04900238 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.03407456 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02933857 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.01645820 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.00325377 |
| 126 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.00053613 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0187080 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0036193 |

